SmurfVA's Random Picks

[Ned Serious]

DARA Conference - I just listened to the archive of the webcast. If you're interested in learning more about KRN5500 (drug up for Orphan Status) kicks in around 18:00 minute mark.

webcast link : http://www.veracast.com/bio/ceoinvestor2014/main/player.cfm?eventid=72264

David Drutz CEO spoke about how well the drug treats neuropathy from Cancer and he said that FDA is still considering the Orphan Status. He did not give any specific updates, but did say that they DO NOT HAVE specific timelines in which they operate. Even though most ODD's seem to take 90days max, he mentioned that its not like it takes 30 days, or 90days. They operate at their own timeline.

Drutz also mentioned that (and of course he's going to hype it) KRN5500 is such a fantastic opportunity, that one could build an entire company JUST around the drug.

With all that said, he talked again about how they needed to do the RevSplit to maintain Nasdaq compliancy, and then will be doing financing at some point in the near future. I believe in their financials they put out recently, the mentioned that they only have enough cash for through Mar, so am expecting financing sometime soon. My guess, and its just a guess, is that they're trying to delay it as long as possible, just in case they get the Orphan approval, and would prefer to do it after that.

Am still going to hold and see what happens. May trim 1/3 still if for some reason it moves up some.